TMOD-02. IDENTIFICATION OF NOVEL MARKERS OF TREATMENT-REFRACTORY RECURRENT GLIOBLASTOMA

Glioblastoma (GBM) is a very aggressive and invasive tumor that relapses within nine months of diagnosis and remains incurable despite advances in multimodal therapy including surgical resection, chemotherapy and radiation. Poor patient outcome has been linked to both marker expression of brain tumo...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Yelle, Nicolas, Chokshi, Chirayu, Vora, Parvez, Venugopal, Chitra, Singh, Sheila
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692073/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1041
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items